{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:24:09Z","timestamp":1649175849515},"reference-count":4,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.2169\/internalmedicine.2135-18","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T17:34:51Z","timestamp":1547055291000},"page":"1197-1197","source":"Crossref","is-referenced-by-count":0,"title":["Nivolumab-related Sclerosing Cholangitis in Gastric Cancer"],"prefix":"10.2169","volume":"58","author":[{"given":"Yoshiharu","family":"Motoo","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Kanazawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kono M, Sakurai T, Okamoto K, et al. Efficacy and safety of chemotherapy following anti-PD-1 antibody therapy for gastric cancer: a case of sclerosing cholangitis. Intern Med 58: 1263-1266, 2019."},{"key":"2","unstructured":"2. Krcik EM. Radiation therapy plus anti-programmed death ligand 1 immunotherapy: a review on overall survival. Radiol Technol 88: 123-128, 2016."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawakami H, Tanizaki J, Tanaka K, et al. Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer. Invest New Drugs 35: 529-536, 2017.","DOI":"10.1007\/s10637-017-0453-0"},{"key":"4","unstructured":"4. Gelsomino F, Vitale G, Ardizzoni A. A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event. Invest New Drugs 36: 144-146, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_2135-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T23:38:21Z","timestamp":1556926701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_2135-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":4,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2135-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}